Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... enables rapid discovery and optimization of broad and potent therapeutic molecules. In July 2020, IDBiologics published results ...

    sommers - 05/26/2021 - 10:39am

  2. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... that activating immune cells with this method may improve therapeutic efficacy and reduce manufacturing expenses.   ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  3. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... critical role of the BMP pathway in stem cell maturation, cholesterol homeostasis and cancer. Dr. Lindsley is a Professor of ... see our work move forward from a basic research program to a therapeutic program in partnership with La Jolla. Together, we see this as an ...

    steelmk - 10/02/2015 - 10:45am

  4. Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease

    ... disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people.  ... the gene encoding PMP22, a protein that snakes through the lipid bilayer of the cell several times until it reaches the cell surface. ...

    sommers - 10/30/2020 - 12:43pm

  5. Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    ... partnership, which is facilitated by the  Center for Technology Transfer and Commercialization,  will promote the development of ... “K ATP  channels have a long history of being useful therapeutic targets for treating type 2 diabetes, hypertension and more ...

    sommers - 02/25/2021 - 9:56am

  6. Tech Connect, Vol. 7, Issue 14: Vanderbilt Cardiac Innovations

    ... 9,545,385    Inhibitors of hemeprotein-catalyzed lipid peroxidation 9,549,720    Robotic device for establishing ... Technology Spotlight: Near-Infrared Dye with Large Stokes ...

    steelmk - 07/21/2017 - 3:15pm

  7. Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

    ... of biochemistry, will continue to lead research and pursue a therapeutic treatment for Charcot-Marie-Tooth disease, a disease that affects ... partnership with Deerfield and grateful to the Center for Technology Transfer and Commercialization team—particularly Alan Bentley and ...

    sommers - 11/17/2020 - 2:53pm

  8. Tech Connect, Vol. 6, Issue 25: CTTC launches new online Invention Disclosure Resources Portal

    ... Vanderbilt technology named one of six technologies to watch in Wall Street Journal ... liver,                                  atherosclerosis and other disorders associated with metabolic syndrome ...

    steelmk - 11/10/2016 - 7:45am

  9. VUMC chikungunya antibody set to enter clinical trial

    ... for the antibody and encapsulated it in their proprietary lipid nanoparticle (LNP) technology, which has been delivered in a Phase I safety trial in human ...

    sommers - 02/27/2019 - 2:41pm

  10. Tech Connect, Vol. 6, Issue 6: VEN kicks off entrepreneurial education series

    ... students in entrepreneurship, lean startup principals and technology commercialization through education, programming and mentorship. ... biomedical research company for the use of Monophosphoryl Lipid A for treatment of antibiotic resistant bacteria, developed by Ed ...

    steelmk - 11/15/2016 - 4:17pm